Atricure to announce fourth quarter and full year 2024 financial results

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2024 financial results on wednesday, february 12, 2025. atricure will host an audio webcast at 4:30 p.m. eastern time on wednesday, february 12, 2025, to discuss its fourth quarter and full year 2024 fin.
ATRC Ratings Summary
ATRC Quant Ranking